![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1375973591237530)
chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese
Description
Read Blog How Much Does Male Enhancement Cost
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://resource.chemlinked.com.cn/baipharm/articles/chinas-glp-1-ra-market-is-fueled-by-glycemic-control-weight-loss-needs.jpg)
Vegetables and carbs go after
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://www.reuters.com/resizer/v2/5LQRQPCDJRILNKQ7VTQVRSTR3Q.jpg?auth=13383a2b0e9aa12e31d1b29d76865b04ec712ccf5deb62f28cb874a7f2aec56f&height=1005&width=1920&quality=80&smart=true)
health agencies have highlighted hundreds of cases of acute pancreatitis, some fatal, in individuals taking semaglutide-based medications such as Ozempic
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://media.licdn.com/dms/image/sync/v2/D4E27AQG5Extsn9yvVA/articleshare-shrink_800/B4EZifZBKIGYAI-/0/1775711444764?e=2147483647&v=beta&t=t2bbcfyUQAgv-dRHvqX-s-EqQIOFlAm9PZxUgJnTmXA)
She started the medication but: Wasn't sure if she was on the right dose Had no guidance on what to eat Wasn't losing weight like her neighbor on the same medication Had no way to ask questions when side effects occurred Felt completely lost and in the dark This isn't just frustratingit's potentially wasteful and ineffective
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iwkIbJcrY7D8/v3/-1x-1.webp)
once daily, to improve convenience and adherence
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://www.reuters.com/resizer/v2/SFS7TG5IGVMGPK7MPIYBQ2FJUM.jpg?auth=40a00539e3b5cba6e8760e36f62c9442d8d2345a8464d27d24c8ba6275ca0803&width=1080&quality=80)
Foundayo (orforglipron) produces an average weight loss of 7.5%11.2% in 72 weeks (about a year and 45 months), according to a study of adults with obesity
![chinese glp 1 China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Updated] GLP-1-RAs Swoop to Chinese](https://www.intage-china.com/files/images/774098407548.png)
